What type of study is this?

This is a Human Clinical Trial study (also classified as: RCT).

December 8, 2025Surgical EndoscopyOpen Access

Ivor Lewis minimally invasive oesophagectomy versus McKeown approach: short-term benefits and mid-term equivalence in a randomized trial for oesophageal squamous cell carcinoma

View Full Paper

Ask AI

Bookmark

Ivor Lewis approach reduces postoperative complications compared to McKeown, enhancing patient recovery.
Postoperative complication rates for anastomotic leak were 8.1% for Ivor Lewis versus 16.9% for McKeown, providing significant evidence.
Randomized controlled trial conducted on 272 patients, evaluating outcomes from two minimally invasive techniques.
Results highlight that despite superior short-term benefits, no significant difference was found in progression-free survival between groups.

No takes yet. Share an insight, caveat, or question.

Randomized trial shows Ivor Lewis reduces postoperative complications in oesophageal cancer, suggesting a preferred option.

An et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark